ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,852.86
-0.55%
Gold vs US Dollar
2,358.865
0.30%
Brent Oil
84.325
1.79%
Bitcoin
68,345.88
-1.51%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Takeda Pharmaceutical Company Ltd (TAK) Share Price

TAK Takeda Pharmaceutical Company Ltd

13.11
-0.01 (-0.08%)
After Hours
Last Updated: 23:32:13
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Takeda Pharmaceutical Company Ltd NYSE:TAK New York Stock Exchange Depository Receipt  ADS each rep 1/2 Share of Common Stock
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.01 -0.08 13.11 0.00 0.00 13.18 13.085 13.14 1,260,697 22:32:13   
*quotes are delayed by at least 20 minutes
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.28T 144.07B 91.0438 0.54 78.09B
 Type  Size  Price  Time  Units 
 13 63,740 13.11 23:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore TAK News
21/05/202411:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
16/05/202413:02PRNCATakeda Canada Inc. conclut une lettre d'intention avec l'Alliance pancanadienne pharmaceutique (APP) concernant LIVTENCITY® (maribavir) pour le traitement des adultes greffés atteints d'une infection à cytomégalovirus (CMV)
16/05/202413:02PRNCATakeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infection
14/05/202413:00BWTakeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
10/05/202412:03BWTakeda annonce ses résultats pour l’exercice 2023 et ses perspectives pour l’exercice 2024, confirmant son engagement en faveur du développement d’un portefeuille de produits à un stade avancé et de l’augmentation de la marge bénéficiaire...
09/05/202422:07BWTakeda veröffentlicht Ergebnisse für das Geschäftsjahr 2023, liefert Ausblick auf das GJ 2024, und bekräftigt Bekenntnis zur Pipeline-Entwicklung in der späten Entwicklungsphase sowie zur Steigerung der operativen Gewinnmarge
09/05/202407:07BW武田薬品工業: 2023年度通期業績および2024年度の見通しを公表 - 後期段階のパイプライン開発とCore営業利益率改善へのコミットメントを強調
Period
Draw mode
Data Downloads for TAK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Takeda Pharmaceutical Company Ltd Articles